Inhibition of c-Kit Is Not Required for Reversal of Hyperglycemia by Imatinib in NOD Mice

(1) AIM/HYPOTHESIS: Recent studies indicate that tyrosine kinase inhibitors, including imatinib, can reverse hyperglycemia in non-obese diabetic (NOD) mice, a model of type 1 diabetes (T1D). Imatinib inhibits c-Abl, c-Kit, and PDGFRs. Next-generation tyrosine kinase inhibitors for T1D treatment shou...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lau, Janet, Zhou, Qiang, Sutton, Susan E., Herman, Ann E., Schmedt, Christian, Glynne, Richard
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3893161/
https://ncbi.nlm.nih.gov/pubmed/24454763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0084900
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires